ROYAL BANK OF CANADA - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 60 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$4,000
-55.6%
700
-56.2%
0.00%
Q1 2018$9,000
+50.0%
1,600
+40.0%
0.00%
Q4 2017$6,000
-64.7%
1,143
-65.0%
0.00%
Q3 2017$17,000
+183.3%
3,268
+195.2%
0.00%
Q2 2017$6,0000.0%1,107
+10.1%
0.00%
Q1 2017$6,000
+200.0%
1,005
+402.5%
0.00%
Q3 2013$2,0002000.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Kalos Management, Inc. 47,500$12,0000.01%
Virtu Financial LLC 94,842$25,0000.00%
ACADIAN ASSET MANAGEMENT LLC 467,425$121,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$6,0000.00%
A.R.T. Advisors, LLC 60,430$16,0000.00%
GOLDMAN SACHS GROUP INC 25,350$7,0000.00%
MORGAN STANLEY 1,019$00.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$6,0000.00%
WOLVERINE TRADING, LLC 30,900$8,0000.00%
WOLVERINE TRADING, LLC 26,779$7,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders